Development of a Transcription Factor-Based Prognostic Model for Predicting the Immune Status and Outcome in Pancreatic Adenocarcinoma
Pancreatic adenocarcinoma (PAAD) is the most common primary malignancy of the pancreas. Growing studies indicate that transcription factors (TFs) are abnormally expressed in PAAD. We, therefore, aimed to evaluate the effect of TFs in PAAD and develop a TF-based prognostic signature for the patients....
Saved in:
| Main Authors: | Xianbin Zhang, Li Li, Peng Liu, Yu Tian, Peng Gong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/4946020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer
by: Jiahui Yuan, et al.
Published: (2025-04-01) -
Predicting immune status and gene mutations in stomach adenocarcinoma patients based on inflammatory response-related prognostic features
by: Huanjun Li, et al.
Published: (2025-04-01) -
Chemokine expression profiles predict overall survival and immune infiltration in patients with pancreatic adenocarcinoma
by: Xinyu Peng, et al.
Published: (2025-03-01) -
Establishment and validation of an immune-related nomogram for the prognosis of pancreatic adenocarcinoma
by: Kan Wang, et al.
Published: (2025-04-01) -
Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma
by: Xin Chen, et al.
Published: (2025-03-01)